Montelukast Unicorn 10 10 mg FC tablet
PDF Leaflet Revision Date: 20 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma in adults and children 15 years and older.
Dosage (summary)
1 tablet (10 mg) daily in the evening; no adjustment for elderly or renal impairment.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnancy and lactation.
Key Drug Interactions
- Phenobarbital
- Gemfibrozil
- CYP inducers
Contraindications
- Hypersensitivity to montelukast
- Pregnancy
- Lactation
- Children under 15
Common side effects
- Headache
- Dizziness
- Abdominal pain
- Upper respiratory infection
Counselling Points
- Take daily as prescribed
- Keep rescue medication available
- Avoid aspirin/NSAIDs if hypersensitive
Serious warnings
- Not for acute asthma attacks
- Risk of Churg-Strauss syndrome
Important Disclaimer
The Montelukast Unicorn 10 10 mg FC tablet professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
